Hepatobiliary tumor
Conditions
Interventions
Observation group:None
Sponsors
West China Hospital of Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Patients with hepatobiliary tumors at Stage I, Stage II, Stage III, and metastatic Stage IV 2.Aged 18–80 years, with no restriction on gender 3.Expected survival time > 6 months before screening for enrollment 4.All subjects are recruited on a voluntary basis, sign the informed consent form, and are willing and able to comply with the study requirements for follow-up, treatment, examinations, and other study-related regulations
Exclusion criteria
Exclusion criteria: 1.Patients with a history of other malignant tumors within the past 5 years 2.Patients with a history of psychotropic substance abuse and addiction, or with mental disorders 3.Patients with concurrent diseases that, as judged by the researcher, may seriously compromise patient safety or prevent patients from completing the study; patients deemed unsuitable for participation 4.Patients with a history of voluntary withdrawal from other clinical trials, or those deemed to have potential risks of voluntary withdrawal from the current study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disease Information;Inspection and Test Report;Medication Information; | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient Basic Information; | — |
Countries
China
Contacts
Public ContactJiayin Yang
West China Hospital of Sichuan University
Outcome results
None listed